Evidence map›Paper›PMID 41053777›Full record

ArticleCritical care (London, England)2025

Xuebijing injection reduces 28-day mortality in patients with septic shock.

Jing Kang, Dingji Hu, Yixuan Li, Lufeng Ma, Hui Chen, Jianfeng Xie, Yi Yang, Tianyi Yang, Zhiqiao Feng, Yan Liu and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jing Kang *Dongzhimen Hospital, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China.
Dingji Hu *Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
Yixuan Li *School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
Lufeng MaTianjin Chasesun Pharmaceutical Co., Ltd., Wuqing Development Zone, 301700, Tianjin, China.
Hui ChenJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
Jianfeng XieJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
Yi YangJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
Tianyi YangInstitute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Jersey, NJ 08901, New Brunswick, United States.
Zhiqiao FengTianjin Chasesun Pharmaceutical Co., Ltd., Wuqing Development Zone, 301700, Tianjin, China.
Yan LiuDongzhimen Hospital, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China.
Haibo QiuJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
Songqiao LiuJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China. liusongqiao@ymail.com.
Chi ZhangDongzhimen Hospital, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China. saga618@126.com.

Funding

National High-level Chinese Medicine Hospital Clinical Study Specific Funding DZMG-LJRC0008Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines 24ZXZKSY00050
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41053777
PMCPMC12502413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.